Tonix Pharmaceuticals Holding short interest in 2026
In 2026, Tonix Pharmaceuticals Holding's disclosed short interest ran from 18.44% of shares outstanding on 15 Jan 2026 to 16.55% on 15 Sep 2026, a change of -1.89 percentage points. The year's high was 22.59% on 31 Jul 2026 and its low 14.70% on 15 May 2026, averaging 18.94% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.16 days on 13 Mar 2026. Full history: Tonix Pharmaceuticals Holding.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2025 · 2026
2026 in figures
- Start of year
- 18.44% (15 Jan 2026)
- End of year
- 16.55% (15 Sep 2026)
- Change
- -1.89 pp
- High
- 22.59% (31 Jul 2026)
- Low
- 14.70% (15 May 2026)
- Average
- 18.94%
- Highest days to cover
- 8.16 (13 Mar 2026)
- SEC filings marked
- 8
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 18.44% | 4.59 | |
| 30 Jan 2026 | 19.81% | 5.43 | |
| 13 Feb 2026 | 20.00% | 7.52 | results (8-K) |
| 27 Feb 2026 | 17.87% | 6.53 | |
| 13 Mar 2026 | 18.45% | 8.16 | 10-K filed, results (8-K) |
| 31 Mar 2026 | 15.48% | 3.68 | |
| 15 Apr 2026 | 18.47% | 5.46 | |
| 30 Apr 2026 | 19.45% | 7.98 | |
| 15 May 2026 | 14.70% | 5.08 | results (8-K), 10-Q filed, results (8-K) |
| 29 May 2026 | 17.99% | 6.22 | |
| 15 Jun 2026 | 19.33% | 5.01 | |
| 30 Jun 2026 | 22.47% | 6.10 | |
| 15 Jul 2026 | 22.49% | 7.23 | |
| 31 Jul 2026 | 22.59% | 7.20 | |
| 14 Aug 2026 | 19.87% | 6.95 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 18.09% | 6.37 | |
| 15 Sep 2026 | 16.55% | 8.14 |
See also: Tonix Pharmaceuticals Holding's full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.